Diabetes

The HCPLive Diabetes condition center page is a comprehensive resource for clinical news and insights on diabetic and cardiometabolic diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for type 1 and type 2 diabetes, as well as related endocrinological conditions and illnesses.

Controlling Chronic Kidney Disease in Type 2 Diabetes

November 26, 2021

Video

Thought leaders discuss recent advances in treatments for patients with type 2 diabetes with chronic kidney disease.

3 Things Primary Care Providers Need to Know About Continuous Glucose Monitoring Technology

November 26, 2021

Article

Type 2 Diabetes: SGLT2 Inhibitors and GLP-1 Receptor Agonists

November 26, 2021

Video

Dennis Bruemmer, MD, PhD, and Jennifer B. Green, MD, have a conversation about the use of SGLT2 inhibitors and GLP1 receptor agonists in treating type 2 diabetes.

CaFFR Guided Revascularization Show Reduced MACE Risk in Diabetic Patients with CAD

November 26, 2021

Article

Patients considered adherent to caFFR had a significantly lower risk of MACE, compared to non-adherent patients (adjusted hazard ratio, 0.33).

Negative Affect, Disinhibited Eating Found In Youth Genetically Predisposed to T2D

November 24, 2021

Article

In models adjusting for age, sex, and race/ethnicity, children with a parent with type 2 diabetes reported higher symptoms of anxiety and depression.

SGLT2 Inhibitors Associated With High Hemoglobin Level, Low Prevalence of Anemia

November 24, 2021

Article

Data show hemoglobin level of SGLT2 inhibitor users were higher at an eGFR above >15 mL/min/1.73m2 compared to non-users.

Obesity Prevalence in United States Linked To Significant Increase Over 4 Decades

November 23, 2021

Article

From 1976 to 2018, data show the prevalence of obesity in the United States increased from 6.2% to 32.7%.

Younger Adults With Diabetes Report Low Receipt of Healthcare During COVID-19

November 23, 2021

Article

Adults aged 18–29 years (87%) with diabetes were more likely to report missed medical care during COVID-19, compared to those aged 30–59 years (63%) or ≥60 years (26%).

Real-World Evidence Shows Automated Insulin Dosing Safe, Effective Treatment for T1D

November 20, 2021

Article

Investigators noted that several types of AID systems improved Time-in-Range and HbA1c with minimal concerns around severe hypoglycemia in type 1 diabetes care.

Standard of Care for Type 2 Diabetes

November 19, 2021

Video

Key opinion leaders review the recent ADA standards of care for type 2 diabetes.